Coronavirus
AstraZeneca and Novavax Claim Their Vaccines Protect Against Omicron
AstraZeneca and Novavax have both announced that their vaccines were able to neutralize the omicron variant of COVID-19.
AstraZeneca announced Thursday that a booster shot of its initial two-dose vaccine regimen successfully neutralized the omicron variant in an Oxford study.
“Neutralizing antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant,” AstraZeneca wrote in its statement, referring to the name of the Oxford-AstraZeneca vaccine.
